PILA PHARMA
@pilapharma.com
Pila Pharma AB, a clinical stage biotech company listed on Nasdaq First North GM in Stockholm, Sweden, is pioneering the development of XEN-D0501, a novel TRPV1 antagonist aimed at revolutionizing diabetes and obesity treatment. Explore our journey as we prepare for a phase 2a clinical trial to evaluate XEN-D0501's safety and potential effects on blood glucose and body weight in overweight or obese individuals with diabetes. | About PILA PHARMA
PILA PHARMA's Company Logos
PILA PHARMA's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#358DD2
Curious Blue
53, 141, 210
206, 64, 52
75, 33, 0, 18
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#00223A
Midnight
0, 34, 58
205, 100, 11
100, 41, 0, 77
About PILA PHARMA
PILA PHARMA is a clinical stage biotech company based in Malmö, Sweden. They specialize in developing innovative treatments for type 2 diabetes and the rare painful disease erythromelalgia. Their flagship product, XEN-D0501, is a potent and selective TRPV1 antagonist that has shown promising results in clinical trials.
With over 300 subjects tested in phase 1 and 2 trials, XEN-D0501 has proven to have a good safety profile and demonstrated efficacy in improving glucose-stimulated insulin secretion in type 2 diabetics. Additionally, preclinical safety studies have been completed without any registration of side effects, allowing the molecule to progress to clinical trials of up to 3 months. In recognition of its potential, XEN-D0501 has received Orphan Drug Designation in the US for the treatment of erythromelalgia.
PILA PHARMA is listed on Nasdaq First North GM, Stockholm, since July 2021, and their Danish subsidiary, Pila Pharma Danmark ApS, is a wholly-owned subsidiary. PILA PHARMA welcomes partners and investors as they move forward in the development of their groundbreaking treatments
Company type
Public Company
Year founded
2014
Company size
2-10 employees
Related Brands
Tags
Clinical-stage biotech
TRPV1 antagonists
Oral drug development
Obesity therapeutics
Type 2 diabetes therapeutics
